
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
Zhuoya Deng, Yuying Tian, Jianxun Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82
Zhuoya Deng, Yuying Tian, Jianxun Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82
Showing 26-50 of 82 citing articles:
On-patient medical record and mRNA therapeutics using intradermal microneedles
Jooli Han, Maria Kanelli, Yang Liu, et al.
Nature Materials (2025)
Open Access
Jooli Han, Maria Kanelli, Yang Liu, et al.
Nature Materials (2025)
Open Access
Bioinformatics analysis reveals novel tumor antigens and immune subtypes of skin cutaneous melanoma contributing to mRNA vaccine development
Ronghua Yang, Jia He, Deni Kang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ronghua Yang, Jia He, Deni Kang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advancement insights in cancer vaccines: mechanisms, types, and clinical applications
Gellan Alaa Mohamed Kamel, Rasha Attia, Hifaa G. Al-Noman, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Gellan Alaa Mohamed Kamel, Rasha Attia, Hifaa G. Al-Noman, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice
Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 14
Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 14
Path towards mRNA delivery for cancer immunotherapy from bench to bedside
Wenfei Chen, Yining Zhu, Jinhan He, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 96-115
Open Access | Times Cited: 14
Wenfei Chen, Yining Zhu, Jinhan He, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 96-115
Open Access | Times Cited: 14
Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)
Shengnan Ren, Zhanyi Zhang, Mengyuan Li, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 12
Shengnan Ren, Zhanyi Zhang, Mengyuan Li, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 12
mRNA‐HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV‐mediated cancers via subcutaneous immunization
Seonghyun Lee, Hyunho Yoon, Seol Hee Hong, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Closed Access | Times Cited: 12
Seonghyun Lee, Hyunho Yoon, Seol Hee Hong, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Closed Access | Times Cited: 12
Ionizable Polymeric Micelles with Phenylalanine Moieties Enhance Intracellular Delivery of Self-Replicating RNA for Long-Lasting Protein Expression In Vivo
Lucas Mixich, Eger Boonstra, Keita Masuda, et al.
Biomacromolecules (2024) Vol. 25, Iss. 2, pp. 1058-1067
Closed Access | Times Cited: 4
Lucas Mixich, Eger Boonstra, Keita Masuda, et al.
Biomacromolecules (2024) Vol. 25, Iss. 2, pp. 1058-1067
Closed Access | Times Cited: 4
Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 4
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 4
Nanodrug Delivery Systems in Antitumor Immunotherapy
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 4
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 4
Effective Synthesis of High-Integrity mRNA Using In Vitro Transcription
Wei He, Xinya Zhang, Yangxiaoyu Zou, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2461-2461
Open Access | Times Cited: 4
Wei He, Xinya Zhang, Yangxiaoyu Zou, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2461-2461
Open Access | Times Cited: 4
Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy
Bevin Neill, Adriana Retamales Romero, Owen S. Fenton
ACS Applied Bio Materials (2023) Vol. 7, Iss. 8, pp. 4894-4913
Open Access | Times Cited: 11
Bevin Neill, Adriana Retamales Romero, Owen S. Fenton
ACS Applied Bio Materials (2023) Vol. 7, Iss. 8, pp. 4894-4913
Open Access | Times Cited: 11
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 10
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 10
Effective synthesis of circRNA via a thermostable T7 RNA polymerase variant as the catalyst
Wei He, Xinya Zhang, Yangxiaoyu Zou, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 3
Wei He, Xinya Zhang, Yangxiaoyu Zou, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 3
Tumor Microenvironment‐Responsive Polymer‐Based RNA Delivery Systems for Cancer Treatment
Yahan Zhang, Ming Zhang, Haiqin Song, et al.
Small Methods (2024)
Closed Access | Times Cited: 3
Yahan Zhang, Ming Zhang, Haiqin Song, et al.
Small Methods (2024)
Closed Access | Times Cited: 3
Immunotherapy in mastitis: state of knowledge, research gaps and way forward
Afnan Saleem, Sahar Saleem, Faith Omonijo, et al.
Veterinary Quarterly (2024) Vol. 44, Iss. 1, pp. 1-23
Open Access | Times Cited: 3
Afnan Saleem, Sahar Saleem, Faith Omonijo, et al.
Veterinary Quarterly (2024) Vol. 44, Iss. 1, pp. 1-23
Open Access | Times Cited: 3
Effect of the COVID-19 pandemic on the pediatric infectious disease landscape
Moshe Shmueli, Idan Lendner, Shalom Ben‐Shimol
European Journal of Pediatrics (2023) Vol. 183, Iss. 3, pp. 1001-1009
Open Access | Times Cited: 9
Moshe Shmueli, Idan Lendner, Shalom Ben‐Shimol
European Journal of Pediatrics (2023) Vol. 183, Iss. 3, pp. 1001-1009
Open Access | Times Cited: 9
Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances
Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Alireza Rezvani, et al.
Life Sciences (2024) Vol. 346, pp. 122652-122652
Closed Access | Times Cited: 2
Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Alireza Rezvani, et al.
Life Sciences (2024) Vol. 346, pp. 122652-122652
Closed Access | Times Cited: 2
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 2
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 2
Low-Dose Mildronate-Derived Lipidoids for Efficient mRNA Vaccine Delivery with Minimal Inflammation Side Effects
Ji‐Wei Liu, Bing Xiao, Yong‐Le Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23289-23300
Closed Access | Times Cited: 2
Ji‐Wei Liu, Bing Xiao, Yong‐Le Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23289-23300
Closed Access | Times Cited: 2
Therapeutic Cancer Vaccines and Their Future Implications
Randa Elsheikh, Abdelrahman M. Makram, Nguyen Tien Huy
Vaccines (2023) Vol. 11, Iss. 3, pp. 660-660
Open Access | Times Cited: 7
Randa Elsheikh, Abdelrahman M. Makram, Nguyen Tien Huy
Vaccines (2023) Vol. 11, Iss. 3, pp. 660-660
Open Access | Times Cited: 7
A View on Drug Development for Cancer Prevention
Andrew R. Reynolds, Michele Moschetta, Alula R. Yohannes, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1058-1083
Open Access | Times Cited: 7
Andrew R. Reynolds, Michele Moschetta, Alula R. Yohannes, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1058-1083
Open Access | Times Cited: 7
Hyperbranched Polymer‐Based Vaccines for Cancer Immunotherapy
Zhiqiang Wang, Yunqi Guo, Mingwu Shen, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 11
Closed Access | Times Cited: 7
Zhiqiang Wang, Yunqi Guo, Mingwu Shen, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 11
Closed Access | Times Cited: 7
Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis
Mahadi Hasan, Anowara Khatun, Kentaro Kogure
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2678-2678
Open Access | Times Cited: 6
Mahadi Hasan, Anowara Khatun, Kentaro Kogure
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2678-2678
Open Access | Times Cited: 6
Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation
Ginette S. Santiago-Sánchez, James W. Hodge, Kellsye P. Fabian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Ginette S. Santiago-Sánchez, James W. Hodge, Kellsye P. Fabian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9